Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP5E | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
mRNA | RP4-614O4.11 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | KDM7A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | EIF6 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | PCDHB11 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | APLP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | RMI1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | GPAT3 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |